Going Out With a Bang--An Interview with Ron Dollens
Executive Summary
Few companies have achieved the kinds of success that Guidant Corp. has in its ten years in existence and few executives have had the impact on the medical device space that Ron Dollens, Guidant's CEO, has had. In this interview, adapted from the Stanford BioDesign Program's "From the Innovator's Work Bench" series, Dollens talks about his career and about the success Guidant has had.
You may also be interested in...
Beyond Medical Devices: An Interview with Medtronic's Bill Hawkins
In a career that has spanned more than 20 years, Bill Hawkins has worked for a wide array of medical device firms, leaving his imprint on this industry. Now, as Medtronic's COO, his influence will only grow. In this interview, Hawkins talks about the history of the device industry and what lies ahead.
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Need a specific report? 1000+ reports available
Buy Reports